Sabra Healthcare REIT (NASDAQ:SBRA) Announces FY 2026 Earnings Guidance

Sabra Healthcare REIT (NASDAQ:SBRA) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided EPS guidance of 1.540-1.550 for the period, compared to the consensus EPS estimate of 1.520.

Analysts Set New Price Targets

A number of research firms have weighed in on SBRA. Mizuho set a $21.00 price target on Sabra Healthcare REIT in a report on Monday, August 31st. Weiss Ratings raised shares of Sabra Healthcare REIT from a “hold (c)” rating to a “buy (b-)” rating in a research report on Tuesday. Robert W. Baird lifted their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research note on Monday, August 31st. Huntington Sec initiated coverage on shares of Sabra Healthcare REIT in a research report on Monday. They set a “strong-buy” rating on the stock. Finally, Barclays reduced their target price on shares of Sabra Healthcare REIT from $23.00 to $21.00 and set an “equal weight” rating on the stock in a research report on Tuesday, October 13th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $21.50.

Sabra Healthcare REIT Price Performance

SBRA stock opened at $20.35 on Wednesday. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.95. Sabra Healthcare REIT has a 52-week low of $17.53 and a 52-week high of $22.77. The stock’s 50 day moving average is $19.85 and its two-hundred day moving average is $19.97. The company has a market capitalization of $5.20 billion, a PE ratio of 72.68, a P/E/G ratio of 1.79 and a beta of 0.68.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.05). The business had revenue of $249.57 million during the quarter, compared to analyst estimates of $236.64 million. Sabra Healthcare REIT had a net margin of 7.78% and a return on equity of 2.56%. The business’s revenue for the quarter was up 31.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.38 earnings per share. Analysts predict that Sabra Healthcare REIT will post 1.52 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Investors of record on Friday, November 13th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.9%. The ex-dividend date is Friday, November 13th. Sabra Healthcare REIT’s payout ratio is 461.54%.

Insider Transactions at Sabra Healthcare REIT

In other Sabra Healthcare REIT news, CEO Richard Matros sold 200,000 shares of the stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the transaction, the chief executive officer directly owned 1,657,686 shares in the company, valued at $34,529,599.38. This represents a 10.77% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.09% of the stock is owned by corporate insiders.

Trending Headlines about Sabra Healthcare REIT

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Sabra raised its 2026 guidance: EPS is now projected at $1.54–$1.55, above the $1.52 consensus, and the midpoint of normalized FFO guidance increased by $0.005 per share. Management also expects 7%–8% year-over-year earnings growth. Sabra Health Care: 3 Key Takeaways for Long-Term Investors
• Positive Sentiment: Third-quarter revenue of about $249.6 million exceeded analyst estimates of $236.6 million and rose 31.4% year over year. Adjusted FFO also topped consensus, according to Zacks. Sabra Healthcare Tops Q3 FFO and Revenue Estimates
• Positive Sentiment: Senior-housing operating portfolio occupancy reached 89.2%, supporting the company’s growth outlook. Sabra also declared a quarterly dividend of $0.30 per share, equivalent to a 6.0% yield based on the provided data. Sabra Reports Third Quarter 2026 Results; Updates 2026 Guidance
• Neutral Sentiment: Sabra aims to increase its senior housing operating portfolio (SHOP) to 50% of its portfolio by year-end 2027, while management sees further upside from nursing-home asset optimization and lease negotiations. The strategy offers growth potential but depends on execution. Sabra Expects Earnings Growth and Targets More SHOP Exposure
• Negative Sentiment: Reported third-quarter net income was $0.11 per diluted share, below the $0.16 analyst consensus and down from $0.38 a year earlier. This earnings miss may temper the positive impact of stronger revenue, FFO, and guidance. Sabra Q3 Earnings Results

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.